Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05004662Completed
Randomised, open-label trial in Tobacco Use Disorder (TUD) (2 arms), sponsored by Moffitt Cancer Center. Primary endpoint: Self-Reported 7-Day Point-Prevalence Smoking Abstinence at 12 months. Started Dec 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05004662.